BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31227283)

  • 1. Damaging Variants in Proangiogenic Genes Impair Growth in Fetuses with Cardiac Defects.
    Russell MW; Moldenhauer JS; Rychik J; Burnham NB; Zullo E; Parry SI; Simmons RA; Elovitz MA; Nicolson SC; Linn RL; Johnson MP; Yu S; Sampson MG; Hakonarson H; Gaynor JW
    J Pediatr; 2019 Oct; 213():103-109. PubMed ID: 31227283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of parental origin of damaging variants in pro-angiogenic genes on fetal growth in patients with congenital heart defects: Data and analyses.
    Russell MW; Moldenhauer JS; Rychik J; Burnham NB; Zullo E; Parry SI; Simmons RA; Elovitz MA; Nicolson SC; Linn RL; Johnson MP; Yu S; Sampson MG; Hakonarson H; Gaynor JW
    Data Brief; 2019 Aug; 25():104311. PubMed ID: 31453292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease.
    Morton SU; Shimamura A; Newburger PE; Opotowsky AR; Quiat D; Pereira AC; Jin SC; Gurvitz M; Brueckner M; Chung WK; Shen Y; Bernstein D; Gelb BD; Giardini A; Goldmuntz E; Kim RW; Lifton RP; Porter GA; Srivastava D; Tristani-Firouzi M; Newburger JW; Seidman JG; Seidman CE
    JAMA Cardiol; 2021 Apr; 6(4):457-462. PubMed ID: 33084842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental vascular malperfusion lesions in fetal congenital heart disease.
    Leon RL; Sharma K; Mir IN; Herrera CL; Brown SL; Spong CY; Chalak LF
    Am J Obstet Gynecol; 2022 Oct; 227(4):620.e1-620.e8. PubMed ID: 35609643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in fetal head biometry and fetoplacental circulation in fetuses with congenital heart defects.
    Ordás P; Rodríguez R; Herrero B; Deiros L; Gómez E; Llurba E; Bartha JL; Antolín E
    Acta Obstet Gynecol Scand; 2022 Sep; 101(9):987-995. PubMed ID: 35726340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extracardiac pathology on head growth in fetuses with congenital heart defect.
    van Nisselrooij AEL; Jansen FAR; van Geloven N; Linskens IH; Pajkrt E; Clur SA; Rammeloo LA; Rozendaal L; van Lith JMM; Blom NA; Haak MC
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):217-225. PubMed ID: 30868678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of genetic variants for birth weight on fetal growth and placental haemodynamics.
    Vermeulen MJ; Gaillard R; Miliku K; Reiss I; Steegers EAP; Jaddoe V; Felix J
    Arch Dis Child Fetal Neonatal Ed; 2020 Jul; 105(4):393-398. PubMed ID: 31666310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth patterns and cerebroplacental hemodynamics in fetuses with congenital heart disease.
    Mebius MJ; Clur SAB; Vink AS; Pajkrt E; Kalteren WS; Kooi EMW; Bos AF; du Marchie Sarvaas GJ; Bilardo CM
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):769-778. PubMed ID: 29808509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small-for-gestational-age fetus?
    Perry H; Lehmann H; Mantovani E; Thilaganathan B; Khalil A
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):210-216. PubMed ID: 31381215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental delayed villous maturation is associated with fetal congenital heart disease.
    O'Hare CB; Mangin-Heimos KS; Gu H; Edmunds M; Bebbington M; Lee CK; He M; Ortinau CM
    Am J Obstet Gynecol; 2023 Feb; 228(2):231.e1-231.e11. PubMed ID: 35985515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital Heart Defects and Indices of Placental and Fetal Growth in a Nationwide Study of 924 422 Liveborn Infants.
    Matthiesen NB; Henriksen TB; Agergaard P; Gaynor JW; Bach CC; Hjortdal VE; Østergaard JR
    Circulation; 2016 Nov; 134(20):1546-1556. PubMed ID: 27742737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive evaluation of genetic variants using chromosomal microarray analysis and exome sequencing in fetuses with congenital heart defect.
    Qiao F; Wang Y; Zhang C; Zhou R; Wu Y; Wang C; Meng L; Mao P; Cheng Q; Luo C; Hu P; Xu Z
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):377-387. PubMed ID: 33142350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of clinically actionable variants from genome sequencing of families with congenital heart disease.
    Alankarage D; Ip E; Szot JO; Munro J; Blue GM; Harrison K; Cuny H; Enriquez A; Troup M; Humphreys DT; Wilson M; Harvey RP; Sholler GF; Graham RM; Ho JWK; Kirk EP; Pachter N; Chapman G; Winlaw DS; Giannoulatou E; Dunwoodie SL
    Genet Med; 2019 May; 21(5):1111-1120. PubMed ID: 30293987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias.
    Miyoshi T; Hosoda H; Nakai M; Nishimura K; Miyazato M; Kangawa K; Ikeda T; Yoshimatsu J; Minamino N
    Am J Obstet Gynecol; 2019 Jan; 220(1):104.e1-104.e15. PubMed ID: 30273582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study.
    Petrovski S; Aggarwal V; Giordano JL; Stosic M; Wou K; Bier L; Spiegel E; Brennan K; Stong N; Jobanputra V; Ren Z; Zhu X; Mebane C; Nahum O; Wang Q; Kamalakaran S; Malone C; Anyane-Yeboa K; Miller R; Levy B; Goldstein DB; Wapner RJ
    Lancet; 2019 Feb; 393(10173):758-767. PubMed ID: 30712878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal Growth in Fetuses with Isolated Cyanotic and Non-Cyanotic Congenital Heart Defects.
    Inversetti A; Fesslova V; Deprest J; Candiani M; Giorgione V; Cavoretto P
    Fetal Diagn Ther; 2020; 47(5):411-419. PubMed ID: 30415250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-D volumetric MRI evaluation of the placenta in fetuses with complex congenital heart disease.
    Andescavage N; Yarish A; Donofrio M; Bulas D; Evangelou I; Vezina G; McCarter R; duPlessis A; Limperopoulos C
    Placenta; 2015 Sep; 36(9):1024-30. PubMed ID: 26190037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is cerebroplacental ratio a marker of impaired fetal growth velocity and adverse pregnancy outcome?
    Khalil A; Morales-Rosello J; Khan N; Nath M; Agarwal P; Bhide A; Papageorghiou A; Thilaganathan B
    Am J Obstet Gynecol; 2017 Jun; 216(6):606.e1-606.e10. PubMed ID: 28189607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal Heart Defects and Measures of Cerebral Size.
    Lauridsen MH; Uldbjerg N; Petersen OB; Vestergaard EM; Matthiesen NB; Henriksen TB; Østergaard JR; Hjortdal VE
    J Pediatr; 2019 Jul; 210():146-153. PubMed ID: 30961987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.